Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid (TXA) for Reduction of Postoperative Blood Transfusion in Hip Fracture Patients
NCT03063892Phase 4Active, not recruiting
- Start
- Aug 2017
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in hip fracture. Started Aug 2017; status: active, not recruiting.
02
Drugs
tranexamic acid
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT03063892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03063892.